MM 11253

CAS No. 345952-44-5

MM 11253( MM-11253 )

Catalog No. M27662 CAS No. 345952-44-5

MM 11253 is a RARγ antagonist with IC50 of 44nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 72 Get Quote
10MG 115 Get Quote
25MG 260 Get Quote
50MG 410 Get Quote
100MG 605 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MM 11253
  • Note
    Research use only, not for human use.
  • Brief Description
    MM 11253 is a RARγ antagonist with IC50 of 44nM.
  • Description
    MM 11253 is a RARγ antagonist with IC50 of 44nM.(In Vitro):MM11253 blocks the ability of MM11254 and MM11389 to inhibit squamous cell carcinoma cell growth .
  • In Vitro
    MM11253 blocks the ability of MM11254 and MM11389 to inhibit squamous cell carcinoma cell growth.
  • In Vivo
    ——
  • Synonyms
    MM-11253
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Retinoid Receptor
  • Recptor
    AMPK α2β2γ1|AMPK α1β1γ1|AMPK α2β1γ1|AMPK α1β2γ1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    345952-44-5
  • Formula Weight
    462.67
  • Molecular Formula
    C28H30O2S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (270.17 mM)
  • SMILES
    CC1(C)CCC(C)(C)c2cc(ccc12)C1(SCCS1)c1ccc2cc(ccc2c1)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhang LN, et al. Novel small-molecule AMP-activated protein kinase allosteric activator with beneficial effects in db/db mice. PLoS One. 2013 Aug 20;8(8):e72092.
molnova catalog
related products
  • K-8012

    K-8012 is a modulator of the N-terminally truncated RXRα and improves anticancer activities in an RXRα-dependent manner.

  • BMS493

    BMS493 is an inverse agonist of the pan-retinoic acid receptor (RAR) that inhibits retinoic acid-induced differentiation, enhances the interaction of nuclear co-inhibitors with RARs, attenuates RA signaling, potentiates TPP-induced toxicity, and inhibits the increase in phospholipase A2 activity.

  • Bexarotene

    Bexarotene is a retinoid specifically selective for retinoid X receptors, used as an oral antineoplastic agent in the treatment of cutaneous T-cell lymphoma.